arrow
C

Charles de Ponthaud

Pitié-Salpêtrière Hospital
H指数:9
被引数:444

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Procedure-specific morbidity and pathologic assessment after resection of small (≤20 mm) pancreatic neuroendocrine tumors

小胰腺神经内分泌肿瘤(≤20 mm)切除后的手术特异性并发症及病理评估

2026-08-200
OAAI
How to Deal with Median Arcuate Ligament during Pancreaticoduodenectomy? Management Strategies and Impact on Perioperative Outcomes

如何在胰十二指肠切除术中处理中弓韧带?管理策略及其对围手术期结局的影响

2026-05-230
OA
Risk prediction model for high-grade dysplasia in resected pancreatic mucinous cystic neoplasms: a nomogram-based approach

高级别上皮内瘤变在切除的胰腺黏液性囊性肿瘤中的风险预测模型:一种基于诺模图的方法

HPB
IF2.4
2026-03-140
PRE
Surgical management of small intestinal neuroendocrine tumors

小肠神经内分泌肿瘤的外科治疗

bjs
IF0
2026-03-040
PRE
Classification of postoperative pancreatic fistula after left pancreatectomy: international multicentre cohort study

左胰腺切除术后胰瘘的分类:国际多中心队列研究

2025-10-300
OA
Impact of neoadjuvant therapy on short-term outcomes after left pancreatectomy: A propensity score–matched international multicenter study

新辅助治疗对左胰腺切除术短期预后的影响:一项倾向性评分匹配的国际多中心研究

Surgery
IF2.7
2025-07-150
OA
ASO Author Reflections: Complete Pathological Response after Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinomas-Curative Surgery in Cured Patients?
2025-02-010
PRE
ASO Visual Abstract: Prognosis Associated with Complete Pathological Response Following Neoadjuvant Treatment for Pancreatic AdenOcarciNOma in the FOFLIRINOX Era: The Multicenter TONO Study
2025-01-290
PRE
Prognosis Associated with Complete Pathological Response Following Neoadjuvant Treatment for PancreaTic AdenOcarciNOma in the FOFLIRINOX Era: the Multicenter TONO Study

Fofirinox时代胰腺腺癌新辅助治疗后完全病理缓解的预后: 多中心TONO研究

2025-01-081
PRE